Le Lézard
Classified in: Health, Science and technology, Business
Subject: ERN

KITS Eyecare Reports Preliminary First Quarter 2024 Results


Q1 Revenue Grew Approximately 23% YOY to Over $34 Million
Cash Position Remains Strong at Approximately $18 Million

VANCOUVER, BC, April 4, 2024 /CNW/ - KITS Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, is providing selected preliminary unaudited results for its first quarter ended March 31, 2024.

Select Preliminary First Quarter 2024 Financial Highlights

"Our business is off to a strong start in 2024," said Roger Hardy, Co-Founder and CEO of KITS. "We continue to grow revenue and customer count at industry-leading levels through our trend-setting product offerings, best-in-class customer experience and value price points. We've been able to sustain our growth momentum while maintaining consistent cost levels to previous quarters as we were able to grow our cash balance in the first quarter. We're proud of how we performed in Q1 and look forward to what we believe will be another banner year at KITS." 

The Company looks forward to reporting its full first quarter 2024 results on May 8, 2024. Details for the first quarter 2024 conference call will be disclosed in the coming weeks.

About KITS
KITS makes eyecare easy. KITS is a leading vertically integrated digital eyecare brand providing eyewear for eyes everywhere. We offer customers access to a vast selection of contact lenses and eyeglasses, including our own exclusive KITS designed products, as well as a robust suite of online vision tools. Our efficient digital platform, backed by our industry-leading manufacturing and designs, removes intermediaries, and enables us to offer great prices and deliver made to order personalized products with incredible care and accuracy. We are creating disruption in the industry by constantly pursuing cutting-edge technologies to enable the best customer experience, including online eyewear fitting tools, and virtual try-on for glasses. We strive to delight our customers with our competitive prices, a convenient digital shopping experience, fast and reliable delivery options, and an unrelenting focus on earning our customers' lifelong trust. For more information on KITS, visit: www.kits.com.

SOURCE KITS


These press releases may also interest you

at 20:06
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343?Anti-Claudin18.2 ADC?as Monotherapy for Advanced Gastric Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC for the Treatment of Advanced Solid Tumors
Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced today that China National Medical Products Administration (NMPA) has...

at 18:45
SHATTERPROOF AND ANTHEM BLUE CROSS AND BLUE SHIELD FOUNDATION PARTNER TO REDUCE HEALTHCARE STIGMA AROUND A SUBSTANCE USE DISORDER
A substance use disorder (SUD) is a complex and often stigmatized health condition that affects countless individuals, families and communities. Stigma against people with a SUD extends beyond individual and interpersonal levels. The Shatterproof...

at 18:35
AARP Responds to 2024 Medicare and Social Security Trustees Reports
AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees Reports released today:...

at 18:35
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING
Nutex Health Inc. ("Nutex Health" or the "Company") , a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks,...

at 18:28
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
Illumina, Inc. today announced that it has publicly filed a Form 10 registration statement with the U.S. Securities and Exchange Commission ("SEC"), in connection with its intended divestiture of GRAIL. A version of this registration statement was...

More news about Health...


News published on and distributed by: